Pharmasset to Present at Two Upcoming C... ( PRINCETON N.J. Sept. 16 2011 /- Pharm...)

Pharmasset to Present at Two Upcoming Conferences

Date:9/16/2011

PRINCETON, N.J., Sept. 16, 2011 /PRNewswire/ -- Pharmasset, Inc. (Nasdaq: VRUS) announces that management will present at the UBS Global Life Sciences Conference to be held September 19 to 21, 2011 at the Grand Hyatt Hotel, New York and the JMP Securities Healthcare Conference to be held September 27 to 28, 2011 at the St. Regis, New York. Schaefer Price, Pharmasset's President and Chief Executive Officer, will provide an overview of the company at the UBS conference on Monday, September 19, 2011 at 10:30 AM (ET) and at the JMP conference on Wednesday, September 28 at 9:00 AM (ET).

To access a simultaneous webcast of Mr. Price's overview via the internet, log on to the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm. Please connect to the website at least ten minutes prior to the start of the presentation to ensure adequate time for a reliable connection and any software download that may be necessary for the webcast.

A replay of the webcasts will be available on Pharmasset's website for thirty days following the conference. The investor presentation will be available for download in PDF format immediately following the presentation in the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm.

About Pharmasset
Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. Our research and development efforts are focused on nucleoside/tide analogs, a class of compounds which act a
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Pharmasset Initiates QUANTUM, a Phase 2b Interferon-Free Trial of PSI-7977 and PSI-938 for All HCV Genotypes
2. Pharmasset Announces Two-for-One Forward Stock Split
3. Pharmasset to Present at Canaccord Genuity Growth Conference
4. Pharmasset Reports Fiscal Third Quarter 2011 Financial Results
5. Pharmasset Announces the Expansion of the ELECTRON Trial in Chronic Hepatitis C
6. Pharmasset to Present at Two Upcoming Investor Conferences
7. Pharmasset Reports Fiscal Second Quarter 2011 Financial Results
8. Pharmasset Initiates Phase 2b ATOMIC Trial of PSI-7977 for Multiple HCV Genotypes
9. Pharmasset to Webcast an Investor Event From the EASL Meeting
10. Pharmasset to Present at Three Upcoming Investor Conferences
11. Pharmasset to Present at the Leerink Swann Hot Topics Roundtable Conference

Post Your Comments:

(Date:5/22/2013)... N.C. , May 22, 2013 STEPh, ... to announce the launch of their web site ( ... [STEPh Reports]. About STEPh Reports ... in development. Each STEPh Report assesses ... trials data, projected launch year, company, and specific key ...

(Date:5/22/2013)... INDEPENDENCE, Ohio , May 22, 2013 ... of health screening services announced today the creation of ... Health (MCM) . MCM is a ... services to MCM,s growing list of clients. These important ... in costly chronic conditions earlier. Effective prevention reduces cost ...

(Date:5/22/2013)... Grifols, ein globales Unternehmen der Gesundheitsbranche ... , Spanien, präsentierte die Ergebnisse einer Studie, ... PROLASTIN©-C (Alpha1-Proteinasehemmer [human]) den Spiegel des Alpha1-Proteins ... Niveau anhebt, das innerhalb des für gesunde ... eine lebensbedrohliche, genetische Erkrankung, bei der der ...

Breaking Medicine Technology:Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2 Life Line Screening and MCM Solutions for Better Health Announce New Partnership 2 Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2 Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3 Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4

[0] Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site [0] Life Line Screening and MCM Solutions for Better Health Announce New Partnership [0] Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt

... Ind., Feb. 14, 2012 Heraeus Kulzer, LLC, the worldwide ... Metal Refining Division donated almost $20,000 to the ... A non-profit organization founded in 2008 with ... Laboratories (NADL), FDLT,s purpose is to advance the profession ...

... 14, 2012 SCOLR Pharma, Inc. (OTCQB: SCLR) announced ... had previously obtained the exclusive worldwide rights to use ... ondansetron, will conduct a bioequivalence trial in Canada. Both ... Canada have reviewed the protocol for the study and ...

Cached Medicine Technology:Heraeus' Precious Metal Refining Division Donates Nearly $20,000 to Foundation for Dental Laboratory Technology 2 Heraeus' Precious Metal Refining Division Donates Nearly $20,000 to Foundation for Dental Laboratory Technology 3 Heraeus' Precious Metal Refining Division Donates Nearly $20,000 to Foundation for Dental Laboratory Technology 4 SCOLR Pharma's Partner to Commence Bioequivalence Study of Ondansetron 2 SCOLR Pharma's Partner to Commence Bioequivalence Study of Ondansetron 3

Heraeus' Precious Metal Refining Division Donates Nearly $20,000 to Foundation for Dental Laboratory Technology SCOLR Pharma's Partner to Commence Bioequivalence Study of Ondansetron

(Date:5/23/2013)... 2013 Shirataki noodles are ... part of a diet strategy. These noodles are originally ... konjac plant. When losing weight, diet and exercise are ... website helping dieters not only research shirataki noodles but ... where to buy them. Shirataki noodles are ...

(Date:5/23/2013)... GBI Research’s analysis indicates that the global ... small number of players accounting for a major proportion of ... growth rate between 2006 and 2012, possibly due to the ... markets, especially in the US. , GBI Research estimates ... billion in 2012, having grown in size at a CAGR ...

(Date:5/22/2013)... Prairie, WI (PRWEB) May 23, 2013 ... , introduced a new feature to its website ... from the agency’s client portfolio through an immersive, 360-degree, ... clients and prospective customers the ability to virtually experience ... a developer of medical technologies and services. Users have ...

(Date:5/22/2013)... CA (PRWEB) May 22, 2013 Dr. Andrew ... to painful scalpel surgery with the Laser Assisted New Attachment ... is raising awareness about the connections between gum disease and ... concerns in the United States today, and is linked to ... of bacteria found in the infected gum pockets. , ...

(Date:5/22/2013)... 2013 Hosted by the California Dental ... clinic provided more than $1.6 million in charitable dental ... San Jose. , The California Dental Association Foundation ... provide free dental services and oral health education to ... third clinic held by CDA and CDAF in the ...

Breaking Medicine News(10 mins):Health News:DietNoodleShop.com is Re-launching; Adding More Diet Recipes Along with Information on Shirataki Noodles 2 Health News:MarketResearch.com Report – Increased Cost of Albumin was Main Factor for Double-Digit Growth of Global Critical Care Market Between 2006 and 2012 2 Health News:Catalyst Exhibits Debuts 360 Degree Virtual Tour of St. Jude Medical Trade Show Booth 2 Health News:For Stroke Awareness Month, Dr. Andrew Satlin is Raising Awareness of the Connections Between Gum Disease and Stroke and Offers Encino, CA Laser Gum Surgery for Treatment 2 Health News:Two-day San Jose Dental Clinic Provides More Than $1.6 Million in Care 2

[0] DietNoodleShop.com is Re-launching; Adding More Diet Recipes Along with Information on Shirataki Noodles [0] MarketResearch.com Report – Increased Cost of Albumin was Main Factor for Double-Digit Growth of Global Critical Care Market Between 2006 and 2012 [0] Catalyst Exhibits Debuts 360 Degree Virtual Tour of St. Jude Medical Trade Show Booth [0] For Stroke Awareness Month, Dr. Andrew Satlin is Raising Awareness of the Connections Between Gum Disease and Stroke and Offers Encino, CA Laser Gum Surgery for Treatment [0] Two-day San Jose Dental Clinic Provides More Than $1.6 Million in Care

... Assisted Living, Home Care and Adult Day Health Care Costs ... The cost of long term care in Idaho ... pressure on those in or near retirement, according to an ... the current economic downturn has led to a decline in ...

... Record Total Net Revenue of $667 Million; , GAAP ... Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty ... ended March 31, 2009. First Quarter 2009 Results ... million or six percent from the first quarter 2008 to ...

... 30 Gentiva Health Services, Inc. (Nasdaq: GTIV ... reported the following 2009 first quarter results: , ... Net revenues of $288.9 million for the quarter ended March ... of $77.8 million from its CareCentrix business unit, for the ...

... CSCX ), a global leader in automated external defibrillator ( AED ... cardiac stress test , Holter , and ... and HIS systems, announced today that it will release its ... close. The Company has scheduled a conference call with analysts and investors ...

... Ill., April 30 If you are among the 60 ... to the Asthma And Allergy Foundation of America) and are ... enjoying a comfortable ride than you may know. Most cars ... that is designed to clean and protect the air inside ...

... - Management Health Solutions, Inc. (MHS) , the leading provider ... has announced improvements to their Clinical Inventory Valuation (CIV) Solution. CIV ... supply process and unlock huge savings. www.mhsinc.com , ... ...

Growth in Idaho Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study Watson Pharmaceuticals Reports First Quarter 2009 Results; Raises 2009 Outlook Gentiva Reports First Quarter 2009 Results Cardiac Science Schedules First Quarter Earnings Release and Announces Conference Call Asthma and Allergy Sufferers: Take in a Breath of Clean Air While Driving Management Health Solutions, Inc. Announces Release v1.0 to Clinical Inventory Valuation Solution

Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....

... and value!, Comfortable feel and ... contoured handle , Finer control while ... action , Completely autoclavable for easy ... for recalibration , Easy-to-read precision micrometer ...

Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....

... the specialty areas of cardiac ... care work, it is essential ... practice. Alokas motorized TEE transducer ... Tissue Harmonic Echo technology allows ...

Medicine Products:

Pipetman P2 SoftGrip 0.2-2 L Adjustable Volume Pipette Pipetman P5000 Motorized TEE Probe